Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024)
Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 200.00% |
| Sep 30, 2020 | 485.71% |
| Jun 30, 2020 | -153.85% |
| Dec 31, 2018 | -53.62% |
| Sep 30, 2018 | -1.39% |
| Jun 30, 2018 | 463.73% |
| Dec 31, 2015 | -12.50% |
| Sep 30, 2015 | -95.74% |
| Jun 30, 2015 | 2,250.00% |
| Mar 31, 2015 | -98.59% |
| Dec 31, 2014 | -60.90% |
| Sep 30, 2014 | 260.70% |
| Jun 30, 2014 | 3,920.00% |
| Mar 31, 2014 | -50.00% |
| Dec 31, 2013 | 300.00% |
| Dec 31, 2012 | -107.14% |
| Sep 30, 2012 | 316.22% |
| Jun 30, 2012 | -71.54% |
| Mar 31, 2012 | 319.35% |
| Dec 31, 2011 | -91.60% |